TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
Research in the area of tuberculosis reported from San Francisco General Hospital
February 17th, 2009
According to recent research from the United States, "Risk factors and treatment outcomes under program conditions for isoniazid (INH)-monoresistant tuberculosis have not been well described. Medical charts were retrospectively reviewed for all cases of culture-confirmed, INH-monoresistant tuberculosis (n=137) reported to the San Francisco Department of Public Health Tuberculosis Control Section from October 1992 through October 2005, and those cases were compared with a time-matched sample of drug-susceptible tuberculosis cases (n=274)." "In multivariate analysis, only a history of treatment for latent tuberculosis (odds ratio [OR], 3.1; 95% confidence interval [CI],...
Source: TB & Outbreaks Week (2009-02-17)
|
